​
​

Tevogen Bio Ownership 2024 | Who Owns Tevogen Bio Now?

OverviewFinancialsChart

Institutional Ownership

8.02%

Insider Ownership

88.94%

Retail Ownership

3.04%

Institutional Holders

7.00

Tevogen Bio Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GLAZER CAPITAL, LLC----149,534-100.00%-Mar 31, 2024
WESTCHESTER CAPITAL MANAGEMENT, LLC----99,949-100.00%-Mar 31, 2024
CENTIVA CAPITAL, LP----100,000-100.00%-Mar 31, 2024
CLEAR STREET LLC----600-100.00%-Mar 31, 2024
KIM, LLC----50,000-100.00%-Mar 31, 2024
METEORA CAPITAL, LLC----505,670-100.00%-Mar 31, 2024
QUARRY LP----55,000-100.00%-Mar 31, 2024

Tevogen Bio's largest institutional shareholder is GLAZER CAPITAL, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GLAZER CAPITAL, LLC----149,534-100.00%-Mar 31, 2024
WESTCHESTER CAPITAL MANAGEMENT, LLC----99,949-100.00%-Mar 31, 2024
CENTIVA CAPITAL, LP----100,000-100.00%-Mar 31, 2024
CLEAR STREET LLC----600-100.00%-Mar 31, 2024
KIM, LLC----50,000-100.00%-Mar 31, 2024
METEORA CAPITAL, LLC----505,670-100.00%-Mar 31, 2024
QUARRY LP----55,000-100.00%-Mar 31, 2024

The largest Tevogen Bio shareholder by % of total assets is GLAZER CAPITAL, LLC. The company owns 0.00 shares of Tevogen Bio (LGST), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CLEAR STREET LLC----600-100.00%-Mar 31, 2024
KIM, LLC----50,000-100.00%-Mar 31, 2024
QUARRY LP----55,000-100.00%-Mar 31, 2024
WESTCHESTER CAPITAL MANAGEMENT, LLC----99,949-100.00%-Mar 31, 2024
CENTIVA CAPITAL, LP----100,000-100.00%-Mar 31, 2024
GLAZER CAPITAL, LLC----149,534-100.00%-Mar 31, 2024
METEORA CAPITAL, LLC----505,670-100.00%-Mar 31, 2024

As of Mar 31 2024, Tevogen Bio's largest institutional buyer is CLEAR STREET LLC. The company purchased -0.60K stocks of LGST, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
METEORA CAPITAL, LLC----505,670-100.00%-Mar 31, 2024
GLAZER CAPITAL, LLC----149,534-100.00%-Mar 31, 2024
CENTIVA CAPITAL, LP----100,000-100.00%-Mar 31, 2024
WESTCHESTER CAPITAL MANAGEMENT, LLC----99,949-100.00%-Mar 31, 2024
QUARRY LP----55,000-100.00%-Mar 31, 2024
KIM, LLC----50,000-100.00%-Mar 31, 2024
CLEAR STREET LLC----600-100.00%-Mar 31, 2024

As of Mar 31 2024, Tevogen Bio's biggest institutional seller is METEORA CAPITAL, LLC. The company sold -0.51M shares of LGST, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
METEORA CAPITAL, LLC----505,670-100.00%-Mar 31, 2024
GLAZER CAPITAL, LLC----149,534-100.00%-Mar 31, 2024
CENTIVA CAPITAL, LP----100,000-100.00%-Mar 31, 2024
WESTCHESTER CAPITAL MANAGEMENT, LLC----99,949-100.00%-Mar 31, 2024
QUARRY LP----55,000-100.00%-Mar 31, 2024
KIM, LLC----50,000-100.00%-Mar 31, 2024
CLEAR STREET LLC----600-100.00%-Mar 31, 2024

Tevogen Bio's largest sold out institutional shareholder by shares sold is METEORA CAPITAL, LLC, sold -0.51M shares, valued at -, as of undefined.

Tevogen Bio Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
Saba Capital Income & Opportunities Fund0.08%196,100--Jan 31, 2024
RIVERPARK FUNDS TRUST0.02%175,000--Dec 31, 2023
CALAMOS INVESTMENT TRUST/IL0.02%2,000,000--Jan 31, 2024
Investment Managers Series Trust II0.02%227,903--Jan 31, 2024
RIVERNORTH OPPORTUNITIES FUND, INC.0.01%6,402--Jan 31, 2024
TRUST FOR PROFESSIONAL MANAGERS0.00%7,865--Feb 29, 2024
PRINCIPAL FUNDS, INC.0.00%1,633--Feb 29, 2024

Tevogen Bio's largest mutual fund holder by % of total assets is "Saba Capital Income & Opportunities Fund", owning 196.10K shares, compromising 0.08% of its total assets.

Tevogen Bio Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
31 Dec, 237-46.15%
30 Sep, 2313160.00%
30 Jun, 235-
31 Mar, 235-92.31%
31 Dec, 22654.84%
30 Sep, 2262-7.46%
30 Jun, 22676.35%
31 Mar, 2263-

As of 31 Dec 23, 7 institutions are holding Tevogen Bio's shares, representing a decrease of -46.15% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Dec, 23960,753-61.16%
30 Sep, 232,473,835-48.37%
30 Jun, 234,791,3970.01%
31 Mar, 234,790,721-86.14%
31 Dec, 2234,575,2218.48%
30 Sep, 2231,871,5192.23%
30 Jun, 2231,176,13114.85%
31 Mar, 2227,144,240-

Tevogen Bio (LGST) has 960.75K shares outstanding as of 31 Dec 23, down -61.16% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Dec, 238.02%1.88%
30 Sep, 2320.64%3.78%
30 Jun, 2323.38%4.28%
31 Mar, 2323.38%0.08%
31 Dec, 22168.72%0.70%
30 Sep, 22155.52%0.67%
30 Jun, 22152.13%0.87%
31 Mar, 22132.46%-

As of 31 Dec 23, Tevogen Bio is held by 8.02% institutional shareholders, representing a 1.88% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Dec, 234-63.64%
30 Sep, 2311450.00%
30 Jun, 232-33.33%
31 Mar, 233-86.36%
31 Dec, 22224.76%
30 Sep, 222110.53%
30 Jun, 2219-69.35%
31 Mar, 2262-

4 institutional shareholders have increased their position in LGST stock as of 31 Dec 23 compared to 11 in the previous quarter (a -63.64% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Dec, 232-
30 Sep, 23--
30 Jun, 23--
31 Mar, 23--100.00%
31 Dec, 221362.50%
30 Sep, 228-
30 Jun, 228-
31 Mar, 22--

2 institutional shareholders have reduced their position in LGST stock as of 31 Dec 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Dec, 237-46.15%960,753-61.16%8.02%1.88%4-63.64%2-
30 Sep, 2313160.00%2,473,835-48.37%20.64%3.78%11450.00%--
30 Jun, 235-4,791,3970.01%23.38%4.28%2-33.33%--
31 Mar, 235-92.31%4,790,721-86.14%23.38%0.08%3-86.36%--100.00%
31 Dec, 22654.84%34,575,2218.48%168.72%0.70%224.76%1362.50%
30 Sep, 2262-7.46%31,871,5192.23%155.52%0.67%2110.53%8-
30 Jun, 22676.35%31,176,13114.85%152.13%0.87%19-69.35%8-
31 Mar, 2263-27,144,240-132.46%-62---

Tevogen Bio Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 18, 2023Corbin Capital Partners, L.P.10 percent owner-S-SaleSell1,716,800$10.68$18.34M-
Jun 08, 2023Semper Paratus Sponsor LLC10 percent owner-S-SaleSell8,988,889$1.00$8.99M4,294,444

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 18, 2023Corbin Capital Partners, L.P.10 percent owner-S-SaleSell1,716,800$10.68$18.34M-
Jun 21, 2023SSVK Associates, LLC10 percent owner-Sell---7,988,889
Jun 14, 2023SSVK Associates, LLC10 percent owner-Sell---1,000,000
Jun 14, 2023SSVK Associates, LLC10 percent owner-Sell7,988,889---
Jun 14, 2023SSVK Associates, LLC10 percent owner-Sell500,000$11.50$5.75M-
Jun 08, 2023Semper Paratus Sponsor LLC10 percent owner-S-SaleSell8,988,889$1.00$8.99M4,294,444

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 18, 2023Corbin Capital Partners, L.P.10 percent owner-S-SaleSell1,716,800$10.68$18.34M-
Jun 21, 2023AJJARAPU SURENDRA Kdirector, 10 percent owner, officer CEO and ChairmanA-AwardBuy7,988,889$1.00$7.99M8,988,889
Jun 21, 2023SSVK Associates, LLC10 percent owner-Sell---7,988,889
Jun 14, 2023AJJARAPU SURENDRA Kdirector, officer CEO and ChairmanBuy----
Jun 14, 2023SSVK Associates, LLC10 percent owner-Sell---1,000,000
Jun 14, 2023SSVK Associates, LLC10 percent owner-Sell7,988,889---
Jun 14, 2023SSVK Associates, LLC10 percent owner-Sell500,000$11.50$5.75M-
Jun 14, 2023Sussman Scott Harrisdirector Buy----
Jun 14, 2023Wadhwani Avinash Rdirector Buy----
Jun 14, 2023PETERSON MICHAEL Ldirector Buy----
Jun 14, 2023Francis Knuettel IIofficer-Buy----
Jun 14, 2023Fell Donald G.director Buy----
Jun 13, 2023Wadhwani Avinash Rdirector Buy----
Jun 12, 2023AJJARAPU SURENDRA Kdirector, 10 percent owner, officer CEO and ChairmanA-AwardBuy7,988,889--7,988,889
Jun 12, 2023AJJARAPU SURENDRA Kdirector, 10 percent owner, officer CEO and ChairmanA-AwardBuy1,000,000$1.00$1.00M1,000,000
Jun 12, 2023AJJARAPU SURENDRA Kdirector, 10 percent owner, officer CEO and ChairmanA-AwardBuy500,000$11.50$5.75M500,000
Jun 08, 2023Semper Paratus Sponsor LLC10 percent owner-S-SaleSell8,988,889$1.00$8.99M4,294,444
Feb 16, 2023Corbin Capital Partners, L.P.10 percent owner-Buy---1,716,800
Feb 16, 2023Corbin Capital Partners, L.P.10 percent owner-Buy---603,200
Feb 01, 2023Semper Paratus Sponsor LLC10 percent owner-C-ConversionBuy11,983,333--13,283,333

The last insider sell of Tevogen Bio's stock was made by Corbin Capital Partners, L.P. on Jul 18 2023, selling 1,716,800 shares at $10.68 per share (valued at $18.34M).

Tevogen Bio Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2023-1-
Q2 20234580.00%
Q1 202311100.00%

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Tevogen Bio's insiders, as of Q3 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2023-1-
Q2 2023-1-
Q1 2023---

As of Q3 2023, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Tevogen Bio's stocks.

Tevogen Bio Peer Ownership

TickerCompany
MOBVMobiv Acquisition Corp
XPDBMontana Technologies Corporation
LCAAL Catterton Asia Acquisition Corp
MAQCMaquia Capital Acquisition Corporation
CETUCetus Capital Acquisition Corp.

LGST Ownership FAQ

Tevogen Bio is owned by institutional shareholders (8.02%), insiders (88.94%), and public (3.04%). The largest institutional shareholder of Tevogen Bio is GLAZER CAPITAL, LLC (0% of total shares) and the top mutual fund owner is Saba Capital Income & Opportunities Fund (0.08% of total shares).

Tevogen Bio's major institutional shareholders are GLAZER CAPITAL, LLC, WESTCHESTER CAPITAL MANAGEMENT, LLC, CENTIVA CAPITAL, LP, CLEAR STREET LLC, and KIM, LLC. The top five shareholders own together 0% of the company's share outstanding.

As of Dec 2023, there are 7 institutional shareholders of Tevogen Bio.

GLAZER CAPITAL, LLC owns 0 shares of Tevogen Bio, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).

As of Mar 2024, WESTCHESTER CAPITAL MANAGEMENT, LLC holds 0 shares of Tevogen Bio (LGST), compromising 0% of the company, valued at $0.

CENTIVA CAPITAL, LP is the third largest holder of Tevogen Bio. The company owns 0 of the company's shares outstanding (worth $0).